Search Results

• • 3,426 

    Academic Journals

  • Sort by: sorttype.publication.date.desc Newest sorttype.publication.date.asc Oldest sorttype.relevance Relevance

• Select Juxtapid

  1

  Juxtapid

  From:Physician Assistants' Prescribing Reference (Vol. 20, Issue 1)

  Spring 2013159 words Brief article 1040LCompany: Aegerion Rx Pharmacologic class: Microsomal triglyceride transfer protein (MTP) inhibitor Active ingredient: Lomitapide mesylate 5mg, 10mg, 20mg; capsules. Indications: As an adjunct to low-fat diet...
• Select 2E Hyperlipoproteinemias

  2

  2E Hyperlipoproteinemias

  From:Nurse Practitioners' Prescribing Reference (Vol. 22, Issue 3) Peer-Reviewed

  Fall 20158,352 words Drug overview 880L>ADVICOR AbbVie Rx Nicotinic acid deriv. + HMG-CoA reductase inhibitor. Niacin ext-rel, lovastatin; 500mg/20mg, 750mg/20mg, 1000mg/20mg, 1000mg/40mg; tabs. Indications: Adjunct to diet in primary...
• Select 2F: Hyperlipoproteinemias

  3

  2F: Hyperlipoproteinemias

  From:Physician Assistants' Prescribing Reference (Vol. 20, Issue 2)

  Summer 20137,965 words Article 850LADVICOR AbbVie Rx Nicotinic acid deriv. + HMG-CoA reductase inhibitor. Niacin ext-rel, lovastatin; 500mg/20mg, 750mg/20mg, 1000mg/20mg, 1000mg/40mg; tabs. Indications: Adjunct to diet in primary...
• Select 2E Hyperlipoproteinemias.

  4

  2E Hyperlipoproteinemias.

  From:MPR - Physician Assistants' Edition (Vol. 21, Issue 3)

  Fall 20148,488 words Article 900LADVICOR AbbVie Rx Nicotinic acid deriv. + HMG-CoA reductase inhibitor. Niacin ext-rel, lovastatin; 500mg/20mg, 750mg/20mg, 1000mg/20mg, 1000mg/40mg; tabs. Indications: Adjunct to diet in primary hypercholesterolemia...
• Select 2E Hyperlipoproteinemias.

  5

  2E Hyperlipoproteinemias.

  From:MPR - Physician Assistants' Edition (Vol. 21, Issue 4)

  Winter 20148,707 words Article 890LADVICOR AbbVie Rx Nicotinic acid deny. + HMG-CoA reductase inhibitor. Niacin ext-rel, lovastatin; 500mg/20mg, 750mg/20mg, 1000mg/20mg, 1000mg/40mg; tabs. Indications: Adjunct to diet in primary hypercholesterolemia...
• Select 2F Hyperlipoproteinemias

  6

  2F Hyperlipoproteinemias

  From:Nurse Practitioners' Prescribing Reference (Vol. 20, Issue 4) Peer-Reviewed

  Winter 20138,479 words Article 890LADVICOR AbbVie Rx Nicotinic acid deriv. + HMG-CoA reductase inhibitor. Niacin ext-rel, lovastatin; 500mg/20mg, 750mg/20mg, 1000mg/20mg, 1000mg/40mg; tabs. Indications: Adjunct to diet in primary...
• Select Kynamro

  7

  Kynamro

  From:Physician Assistants' Prescribing Reference (Vol. 20, Issue 2)

  Summer 2013156 words Brief article 1190LCompany: Genzyme Rx Pharmacologic class: Oligonucleotide inhibitor of Apo B-100 synthesis Active ingredient: Mipomersen sodium 200mg/mL; solution for SC injection; preservative-free. Indication: Adjunct to...
• Select 2F Hyperlipoproteinemias

  8

  2F Hyperlipoproteinemias

  From:Nurse Practitioners' Prescribing Reference (Vol. 21, Issue 1) Peer-Reviewed

  Spring 20148,313 words Drug overview 880LADVICOR AbbVie Rx Nicotinic acid deriv. + HMG-CoA reductase inhibitor. Niacin ext-rel, lovastatin; 500mg/20mg, 750mg/20mg, 1000mg/20mg, 1000mg/40mg; tabs. Indications: Adjunct to diet in primary...
• Select 2E Hyperlipoproteinemias

  9

  2E Hyperlipoproteinemias

  From:Nurse Practitioners' Prescribing Reference (Vol. 22, Issue 4) Peer-Reviewed

  Winter 20158,146 words Article 890L> ADVICOR AbbVie Rx Nicotinic acid deriv. + HMG-CoA reductase inhibitor. Niacin ext-rel, lovastatin; 500mg/20mg, 750mg/20mg, 1000mg/20mg, 1000mg/40mg; tabs. Indications: Adjunct to diet in primary...
• Select Liptruzet, a combo lipid Tx

  10

  Liptruzet, a combo lipid Tx

  From:Physician Assistants' Prescribing Reference (Vol. 20, Issue 2)

  Summer 2013112 words Brief article 1370LThe FDA has approved Liptruzet (ezetimibe and atorvastatin; Merck) for the treatment of elevated low-density lipoprotein (LDL) cholesterol in patient with primary or mixed hyperlipidemia as adjunctive therapy to diet...
• Select Crestor for 10-17yr olds

  11

  Crestor for 10-17yr olds

  From:Physician Assistants' Prescribing Reference (Vol. 16, Issue 4)

  Winter 200938 words Brief article Crestor (rosuvastatin calcium tabs, from AstraZeneca) has been approved for use in boys and postmenarchal girls 10-17 years of age with heterozygous familial hypercholesterolemia after failing an adequate trial of diet...
• Select 2E Hyperlipoproteinemias.

  12

  2E Hyperlipoproteinemias.

  From:MPR - Physician Assistants' Edition (Vol. 22, Issue 2)

  Summer 20158,542 words Article 890LADVICOR AbbVie Rx Nicotinic acid deriv. + HMG-CoA reductase inhibitor. Niacin ext-rel, lovastatin; 500mg/20mg, 750mg/20mg, 1000mg/20mg, 1000mg/40mg; tabs. Indications: Adjunct to diet in primary hypercholesterolemia...
• Select 2E Hyperlipoproteinemias.

  13

  2E Hyperlipoproteinemias.

  From:MPR - Physician Assistants' Edition (Vol. 22, Issue 1)

  Spring 20158,647 words Article 900LADVICOR AbbVie Rx Nicotinic acid deriv. + HMG-CoA reductase inhibitor. Niacin ext-rel, lovastatin; 500mg/20mg, 750mg/20mg, 1000mg/20mg, 1000mg/40mg; tabs. Indications: Adjunct to diet in primary hypercholesterolemia...
• Select 2F Hyperlipoproteinemias.

  14

  2F Hyperlipoproteinemias.

  From:MPR - Physician Assistants' Edition (Vol. 20, Issue 4)

  Winter 20138,540 words Article 870LADVICOR AbbVie Rx Nicotinic acid deriv. + HMG-CoA reductase inhibitor. Niacin ext-rel, lovastatin; 500mg/20mg, 750mg/20mg, 1000mg/20mg, 1000mg/40mg; tabs. Indications: Adjunct to diet in primary hypercholesterolemia...
• Select Repatha.

  15

  Repatha.

  From:MPR - Physician Assistants' Edition (Vol. 22, Issue 4)

  Winter 2015157 words Brief article 1120LCompany: Amgen | Rx Pharmacologic class: Proprotein convertase subtilisin kexin type 9 (PCSK9) inhibitor Active ingredient: Evolocumab 140mg/mL; solution for SC injection; preservative-free. Indication: Adjunct to...
• Select 2E Hyperlipoproteinemias.

  16

  2E Hyperlipoproteinemias.

  From:MPR - Physician Assistants' Edition (Vol. 22, Issue 4)

  Winter 20158,170 words Article 890LADVICOR AbbVie Rx Nicotinic acid deriv. + HMG-CoA reductase inhibitor. Niacin ext-rel, lovastatin; 500mg/20mg, 750mg/20mg, 1000mg/20mg, 1000mg/40mg; tabs. Indications: Adjunct to diet in primary hypercholesterolemia...
• Select 2F Hyperlipoproteinemias.

  17

  2F Hyperlipoproteinemias.

  From:MPR - Physician Assistants' Edition (Vol. 21, Issue 1)

  Spring 20148,193 words Article 890LADVICOR AbbVie Rx Nicotinic acid deriv. + HMG-CoA reduciase inhibitor. Niacin ext-rel, lovastatin; 500mg/20mg, 750mg/20mg, 1000mg/20mg, 1000mg/40mg; tabs. Indications: Adjunct to diet in primary hypercholesterolemia...
• Select 2E Hyperlipoproteinemias.

  18

  2E Hyperlipoproteinemias.

  From:MPR - Physician Assistants' Edition (Vol. 22, Issue 3)

  Fall 20158,297 words Article 900L>ADVICOR AbbVie Rx Nicotinic acid deriv. + HMG-CoA reductase inhibitor. Niacin ext-rel, lovastatin; 500mg/20mg, 750mg/20mg, 1000mg/20mg, 1000mg/40mg; tabs. Indications: Adjunct to diet in primary hypercholesterolemia...
• Select 2E Hyperlipoproteinemias.

  19

  2E Hyperlipoproteinemias.

  From:MPR - Physician Assistants' Edition (Vol. 23, Issue 2)

  Summer 20168,187 words Article 900L>ADVICOR AbbVie Rx Nicotinic acid deriv. + HMG-CoA reductase inhibitor. Niacin ext-rel, lovastatin; 500mg/ 20mg, 750mg/20mg, 1000mg/20mg, 1000mg/40mg; tabs. Indications: Adjunct to diet in primary...
• Select Kynamro OK'd for HoFH

  20

  Kynamro OK'd for HoFH

  From:Nurse Practitioners' Prescribing Reference (Vol. 20, Issue 1) Peer-Reviewed

  Spring 201367 words Brief article 1360LKynamro, (mipomersen sodium; Genzyme and Isis) a weekly SC injection, has been approved as an adjunct to lipid-lowering medications and diet to reduce LDL-C, ApoB, total cholesterol, and non HDL-C in patients with...